{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:51:15Z","timestamp":1777463475021,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40266-023-01006-8","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T10:02:31Z","timestamp":1677146551000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inappropriate Combined Antiplatelet and Anticoagulant Therapy in Older Patients with Atrial Fibrillation: Trend over Time (2009\u201318)"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7695-6461","authenticated-orcid":false,"given":"Emilie","family":"Philippe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-8093","authenticated-orcid":false,"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5857-3085","authenticated-orcid":false,"given":"Benoit","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Marien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"issue":"21","key":"1006_CR1","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719\u201347. https:\/\/doi.org\/10.1093\/eurheartj\/ehs253. (PubMed PMID: 22922413).","journal-title":"Eur Heart J"},{"issue":"2","key":"1006_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1684\/pnv.2013.0407","volume":"11","author":"O Hanon","year":"2013","unstructured":"Hanon O, Assayag P, Belmin J, et al. Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people. Geriatr Psychol Neuropsychiatr Vieil. 2013;11(2):117\u201343. https:\/\/doi.org\/10.1684\/pnv.2013.0407. (PubMed PMID: 23803629).","journal-title":"Geriatr Psychol Neuropsychiatr Vieil."},{"issue":"5","key":"1006_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","volume":"50","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1-88. https:\/\/doi.org\/10.1093\/ejcts\/ezw313. (PubMed PMID: 27663299).","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"1006_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","volume":"381","author":"S Yasuda","year":"2019","unstructured":"Yasuda S, Kaikita K, Akao M, et al. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019;381(12):1103\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1904143. (PubMed PMID: 31475793).","journal-title":"N Engl J Med"},{"issue":"6","key":"1006_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/CIRCULATIONAHA.118.036248","volume":"139","author":"N van Rein","year":"2019","unstructured":"van Rein N, Heide-Jorgensen U, Lijfering WM, et al. Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy. Circulation. 2019;139(6):775\u201386. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036248. (PubMed PMID: 30586754).","journal-title":"Circulation"},{"issue":"15","key":"1006_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","volume":"129","author":"M Lamberts","year":"2014","unstructured":"Lamberts M, Gislason GH, Lip GY, et al. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation. 2014;129(15):1577\u201385. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004834. (PubMed PMID: 24470482).","journal-title":"Circulation"},{"issue":"5","key":"1006_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","volume":"152","author":"GC Flaker","year":"2006","unstructured":"Flaker GC, Gruber M, Connolly SJ, et al. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Am Heart J. 2006;152(5):967\u201373. https:\/\/doi.org\/10.1016\/j.ahj.2006.06.024. (PubMed PMID: 17070169).","journal-title":"Am Heart J"},{"issue":"20","key":"1006_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1136\/heartjnl-2014-305486","volume":"100","author":"R De Caterina","year":"2014","unstructured":"De Caterina R, Ammentorp B, Darius H, et al. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. Heart. 2014;100(20):1625\u201335. https:\/\/doi.org\/10.1136\/heartjnl-2014-305486. (PubMed PMID: 25106421).","journal-title":"Heart"},{"issue":"10","key":"1006_CR9","doi-asserted-by":"publisher","first-page":"e13161","DOI":"10.1111\/eci.13161","volume":"49","author":"G Elvira Ruiz","year":"2019","unstructured":"Elvira Ruiz G, Caro Martinez C, Flores Blanco PJ, et al. Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists. Eur J Clin Invest. 2019;49(10):e13161. https:\/\/doi.org\/10.1111\/eci.13161. (PubMed PMID: 31449685).","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"1006_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.advms.2017.06.005","volume":"63","author":"E Michniewicz","year":"2018","unstructured":"Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease: double trouble. Adv Med Sci. 2018;63(1):30\u20135. https:\/\/doi.org\/10.1016\/j.advms.2017.06.005. (PubMed PMID: 28818746).","journal-title":"Adv Med Sci"},{"key":"1006_CR11","doi-asserted-by":"publisher","first-page":"j5058","DOI":"10.1136\/bmj.j5058","volume":"359","author":"JA Lopez-Lopez","year":"2017","unstructured":"Lopez-Lopez JA, Sterne JAC, Thom HHZ, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 2017;359:j5058. https:\/\/doi.org\/10.1136\/bmj.j5058. (PubMed PMID: 29183961; PubMed Central PMCID: PMCPMC5704695).","journal-title":"BMJ"},{"issue":"11","key":"1006_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40266-017-0493-3","volume":"34","author":"S Henrard","year":"2017","unstructured":"Henrard S, Vandenabeele C, Marien S, et al. Underuse of anticoagulation in older patients with atrial fibrillation and CHADS2 score \u22652: are we doing better since the marketing of direct oral anticoagulants? Drugs Aging. 2017;34(11):841\u201350. https:\/\/doi.org\/10.1007\/s40266-017-0493-3. (PubMed PMID: 29086350).","journal-title":"Drugs Aging"},{"issue":"2","key":"1006_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ageing\/afw233","volume":"46","author":"R Galvin","year":"2017","unstructured":"Galvin R, Gilleit Y, Wallace E, et al. Adverse outcomes in older adults attending emergency departments: a systematic review and meta-analysis of the Identification of Seniors At Risk (ISAR) screening tool. Age Ageing. 2017;46(2):179\u201386. https:\/\/doi.org\/10.1093\/ageing\/afw233. (PubMed PMID: 27989992).","journal-title":"Age Ageing"},{"key":"1006_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2147\/CIA.S62597","volume":"9","author":"F Maes","year":"2014","unstructured":"Maes F, Dalleur O, Henrard S, et al. Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation? Clin Interv Aging. 2014;9:1091\u20139. https:\/\/doi.org\/10.2147\/CIA.S62597. (PubMed PMID: 25053883; PubMed Central PMCID: PMCPMC4105275).","journal-title":"Clin Interv Aging"},{"issue":"4","key":"1006_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamainternmed.2018.7816","volume":"179","author":"JK Schaefer","year":"2019","unstructured":"Schaefer JK, Li Y, Gu X, et al. Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events. JAMA Intern Med. 2019;179(4):533\u201341. https:\/\/doi.org\/10.1001\/jamainternmed.2018.7816. (PubMed PMID: 30830172; PubMed Central PMCID: PMCPMC6450296).","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1006_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11239-016-1425-5","volume":"43","author":"CH So","year":"2017","unstructured":"So CH, Eckman MH. Combined aspirin and anticoagulant therapy in patients with atrial fibrillation. J Thromb Thrombolysis. 2017;43(1):7\u201317. https:\/\/doi.org\/10.1007\/s11239-016-1425-5. (PubMed PMID: 27665101; PubMed Central PMCID: PMCPMC5235980).","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"1006_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1253\/circj.CJ-20-0373","volume":"85","author":"M Ohta","year":"2021","unstructured":"Ohta M, Hayashi K, Mori Y, et al. Impact of frailty on bleeding events related to anticoagulation therapy in patients with atrial fibrillation. Circ J. 2021;85(3):235\u201342. https:\/\/doi.org\/10.1253\/circj.CJ-20-0373. (PubMed PMID: 33504742).","journal-title":"Circ J"},{"issue":"1","key":"1006_CR18","doi-asserted-by":"publisher","first-page":"e018905","DOI":"10.1136\/bmjopen-2017-018905","volume":"8","author":"PN Apenteng","year":"2018","unstructured":"Apenteng PN, Gao H, Hobbs FR, et al. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry. BMJ Open. 2018;8(1):e018905. https:\/\/doi.org\/10.1136\/bmjopen-2017-018905. (PubMed PMID: 29331969; PubMed Central PMCID: PMCPMC5781154).","journal-title":"BMJ Open"},{"issue":"16","key":"1006_CR19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499\u2013508. https:\/\/doi.org\/10.1056\/NEJMoa1800722. (PubMed PMID: 30221596; PubMed Central PMCID: PMCPMC6426126).","journal-title":"N Engl J Med"},{"issue":"5","key":"1006_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/HCO.0000000000000648","volume":"34","author":"T Knickelbine","year":"2019","unstructured":"Knickelbine T, Miedema MD. Aspirin for primary prevention of cardiovascular disease: is it time to move on? Curr Opin Cardiol. 2019;34(5):510\u20133. https:\/\/doi.org\/10.1097\/HCO.0000000000000648. (PubMed PMID: 31219876).","journal-title":"Curr Opin Cardiol"},{"issue":"19","key":"1006_CR21","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, European Heart Rhythm Associaton; European Association for Cardio-Thoracic Surgery, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369\u2013429. https:\/\/doi.org\/10.1093\/eurheartj\/ehq278. (PubMed PMID: 20802247).","journal-title":"Eur Heart J"},{"issue":"1","key":"1006_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jgs.13200","volume":"63","author":"O Bahri","year":"2015","unstructured":"Bahri O, Roca F, Lechani T, et al. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude. J Am Geriatr Soc. 2015;63(1):71\u20136. https:\/\/doi.org\/10.1111\/jgs.13200. (PubMed PMID: 25597559).","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1006_CR23","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/jgs.16400","volume":"68","author":"A Lampart","year":"2020","unstructured":"Lampart A, Kuster T, Nickel CH, et al. Prevalence and severity of traumatic intracranial hemorrhage in older adults with low-energy falls. J Am Geriatr Soc. 2020;68(5):977\u201382. https:\/\/doi.org\/10.1111\/jgs.16400. (PubMed PMID: 32142155).","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1006_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/europace\/euaa017","volume":"22","author":"S Raposeiras-Roubin","year":"2020","unstructured":"Raposeiras-Roubin S, Abu-Assi E, Paz RC, et al. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation. Europace. 2020;22(6):878\u201387. https:\/\/doi.org\/10.1093\/europace\/euaa017. (PubMed PMID: 32167562).","journal-title":"Europace"},{"issue":"2","key":"1006_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jjcc.2020.10.008","volume":"77","author":"M Shinohara","year":"2021","unstructured":"Shinohara M, Wada R, Yano K, et al. Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants. J Cardiol. 2021;77(2):147\u201353. https:\/\/doi.org\/10.1016\/j.jjcc.2020.10.008. (PubMed PMID: 33371946).","journal-title":"J Cardiol"},{"issue":"3","key":"1006_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCRESAHA.118.313155","volume":"124","author":"NC Chan","year":"2019","unstructured":"Chan NC, Weitz JI. Antithrombotic agents. Circ Res. 2019;124(3):426\u201336. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313155. (PubMed PMID: 30702990).","journal-title":"Circ Res"},{"key":"1006_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2020.04.035","volume":"191","author":"A Delluc","year":"2020","unstructured":"Delluc A, Lacut K, Rodger MA. Arterial and venous thrombosis: what\u2019s the link? A narrative review Thromb Res. 2020;191:97\u2013102. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.035. (PubMed PMID: 32416310).","journal-title":"A narrative review. Thromb Res."},{"issue":"7","key":"1006_CR28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/jth.13697","volume":"15","author":"M Melkonian","year":"2017","unstructured":"Melkonian M, Jarzebowski W, Pautas E, et al. Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis. J Thromb Haemost. 2017;15(7):1500\u201310. https:\/\/doi.org\/10.1111\/jth.13697. (PubMed PMID: 28393461).","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1006_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archinte.167.2.117","volume":"167","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Lim W, et al. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med. 2007;167(2):117\u201324. https:\/\/doi.org\/10.1001\/archinte.167.2.117. (PubMed PMID: 17242311).","journal-title":"Arch Intern Med"},{"issue":"270","key":"1006_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijcard.2018.06.098","volume":"1","author":"G Patti","year":"2018","unstructured":"Patti G, Pecen L, Lucerna M, et al. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy: a pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Int J Cardiol. 2018;1(270):160\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.098. (PubMed PMID: 30220376).","journal-title":"Int J Cardiol"},{"issue":"264","key":"1006_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2018.03.018","volume":"1","author":"Q Fischer","year":"2018","unstructured":"Fischer Q, Georges JL, Le Feuvre C, et al. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: \u201cOLTAT registry.\u201d Int J Cardiol. 2018;1(264):64\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.018. (PubMed PMID: 29776575).","journal-title":"Int J Cardiol"},{"issue":"10","key":"1006_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/clc.22750","volume":"40","author":"G Lemesle","year":"2017","unstructured":"Lemesle G, Ducrocq G, Elbez Y, et al. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: association with ischemic and bleeding events. Clin Cardiol. 2017;40(10):932\u20139. https:\/\/doi.org\/10.1002\/clc.22750. (PubMed PMID: 28692742).","journal-title":"Clin Cardiol"},{"key":"1006_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ahj.2019.04.007","volume":"213","author":"T Inohara","year":"2019","unstructured":"Inohara T, Shrader P, Pieper K, et al. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019;213:81\u201390. https:\/\/doi.org\/10.1016\/j.ahj.2019.04.007. (PubMed PMID: 31129441).","journal-title":"Am Heart J"},{"issue":"2","key":"1006_CR34","doi-asserted-by":"publisher","first-page":"e200107","DOI":"10.1001\/jamanetworkopen.2020.0107","volume":"3","author":"KAA Fox","year":"2020","unstructured":"Fox KAA, Velentgas P, Camm AJ, et al. Outcomes associated with oral anticoagulants plus antiplatelets in patients with newly diagnosed atrial fibrillation. JAMA Netw Open. 2020;3(2):e200107. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.0107. (PubMed PMID: 32101311; PubMed Central PMCID: PMCPMC7137686).","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1006_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CRD.0000000000000088","volume":"24","author":"S Kumar","year":"2016","unstructured":"Kumar S, Danik SB, Altman RK, et al. Non-vitamin K antagonist oral anticoagulants and antiplatelet therapy for stroke prevention in patients with atrial fibrillation: a meta-analysis of randomized controlled trials. Cardiol Rev. 2016;24(5):218\u201323. https:\/\/doi.org\/10.1097\/CRD.0000000000000088. (PubMed PMID: 26274538).","journal-title":"Cardiol Rev"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01006-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01006-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01006-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T02:58:43Z","timestamp":1679885923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01006-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1006"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01006-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"18 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Emilie Philippe, S\u00e9verine Henrard, Benoit Boland, and Sophie Marien have no potential conflicts of interest that might be relevant to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"The study protocol was approved by the Comit\u00e9 d\u2019Ethique Hospitalo-Facultaire, Cliniques Univeritaires Saint-Luc, Universit\u00e9 Catholique de Louvain (reference 2018\/14FEV\/063, registration number B403).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Considering the signification proportion of deceased patients included in this study, related to its retrospective nature and the age and frailty of the cohort included, we elected not to ask for informed consent, so as not to cause undue distress to deceased patients\u2019 families.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets that support the findings of this study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors have made significant contributions to the study. EP, SH, and SM conceptualized and designed the study. EP, BB, and SM worked on the literature review and data collection. EP performed the initial analysis and interpretation of the data while SH performed the formal statistical analysis. EP and SM drafted the manuscript and all authors contributed to critically revising it. All the authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}